Zobrazeno 1 - 10
of 15
pro vyhledávání: '"J. E. Godwin"'
Autor:
A. Sehgal, D. Hoda, P. A. Riedell, N. Ghosh, M. Hamadani, G. C. Hildebrandt, J. E. Godwin, P. Reagan, N. Wagner-Johnston, J. Essell, R. Nath, S. R. Solomon, R. Champion, E. Licitra, S. Fanning, N. Gupta, R. Dubowy, A. D’Andrea, L. Wang, L. I. Gordon
Publikováno v:
HemaSphere, Vol 6, Pp 159-160 (2022)
Externí odkaz:
https://doaj.org/article/4f00b6c8a2274e36b790862b61fe628b
Autor:
Jay Courtright, Nikolaus S. Trede, Daanish Hoda, Habte A. Yimer, Paul Shaughnessy, J. Essell, Don A. Stevens, James Lymp, J. C. Varela, Suzanne R. Fanning, C.R. Bachier, Mohamad Cherry, Marina Youssef, Jeffrey P. Sharman, J. E. Godwin, Michael B. Maris, B. Mattar
Publikováno v:
Hematological Oncology. 39
Autor:
Nikolaus S. Trede, C.R. Bachier, James Lymp, Michael B. Maris, Lei Wang, Ana Kostic, J. E. Godwin, Alison R. Sehgal, Gerhard C. Hildebrandt
Publikováno v:
Hematological Oncology. 37:502-503
Publikováno v:
Thrombosis and Haemostasis. 66:575-580
SummaryMaywood I is a dysfunctional plasminogen. It is described in a patient (W. Y) with a reduced plasma functional activity and with a low normal antigen level. Plasminogen was isolated from the patients plasma by affinity chromatography with L-ly
Publikováno v:
DICP. 24:959-970
Among the many advances made in intensive care therapeutics in recent years, few have rivaled the impact of mechanical ventilators. Their expanded use affects all who practice in the critical care setting. This article reviews the physiologic basis f
Autor:
D D, Shin, J E, Godwin
Publikováno v:
American journal of hematology. 60(3)
Takayasu's arteritis (TA) is a rare, chronic, and idiopathic vasculitis of the aorta and/or its main branches. There have been case reports of this disease associated with immune hypercoaguable states, namely raised antiphospholipid antibodies. Inves
Autor:
C P, Leith, I M, Chen, K J, Kopecky, F R, Appelbaum, D R, Head, J E, Godwin, J K, Weick, C L, Willman
Publikováno v:
Blood. 86(6)
Resistance to chemotherapy is a major factor limiting successful treatment of acute myeloid leukemia (AML); one of the best characterized drug resistance mechanisms is extrusion of drugs by the energy-dependent multidrug resistance (MDR1) transport p
Publikováno v:
Blood. 83(2)
In this phase I/II study, 9 patients with myelodysplastic syndromes (MDS) were treated with interleukin-3 (IL-3) followed by granulocyte-macrophage colony-stimulating factor (GM-CSF). Each treatment cycle was 28 days long and administered as follows:
Autor:
L, Elias, D, Stock-Novack, D R, Head, M R, Grever, J K, Weick, R A, Chapman, J E, Godwin, E N, Metz, F R, Appelbaum
Publikováno v:
Leukemia. 7(3)
Fludarabine monophosphate is a new antimetabolite with demonstrated activity in chronic lymphocytic leukemia (CLL). We have investigated the practicality of utilizing fludarabine in combination with chlorambucil in a disease-specific phase I trial. T
Publikováno v:
Cancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 1(3)
The association between occupational and other environmental exposures was evaluated in 60 acute myelogenous leukemia cases and controls. Odds ratios and 95% confidence intervals for prior cytotoxic therapy and benzene exposure, adjusted for age, sex